The multiport surgical robot market is set to reach $6.93 billion by 2030 at a 19.1% CAGR, driven by complex robotic procedures, AI-assisted surgery, and minimally invasive robotics.
Read MoreThe multimodal imaging market is projected to reach $6 billion by 2030 at a 6.8% CAGR, driven by hybrid imaging systems, AI analytics, and precision diagnostics demand.
Read MoreThe monogenetic disease therapy market is set to reach $45.58 billion by 2030 at a 10.0% CAGR, driven by gene editing advances and precision genetic treatments.
Read MoreThe mobile health monitoring diagnostic device market is projected to reach $107.69 billion by 2030 at a 19.8% CAGR, driven by remote diagnostics and connected care growth.
Read MoreThe mobile health (mHealth) device market is set to reach $105.17 billion by 2030 at a 14.7% CAGR, driven by wearables, remote monitoring, and connected care solutions.
Read MoreThe MAPK inhibitors market is projected to reach $5.22 billion by 2030 at an 11.3% CAGR, driven by targeted oncology therapies and personalized cancer care growth.
Read MoreThe miniature brain stimulator market is set to reach $1.57 billion by 2030 at a 9.2% CAGR, driven by neuromodulation advances and compact implantable devices.
Read MoreThe micro-surgical robot market is projected to reach $2.7 billion by 2030 at a 13.0% CAGR, driven by ultra-precise surgery, robotic ORs, and imaging-guided microsurgery.
Read MoreThe mRNA manufacturing service market is projected to reach $12.97 billion by 2030 at a 16.2% CAGR, driven by therapy trials, outsourcing demand, and GMP-scale production.
Read MoreThe mRNA and next-generation vaccine platforms market is set to reach $82.61 billion by 2030 at a 15.8% CAGR, driven by cancer vaccines and rapid platform innovation.
Read More